The accessibility to gene panel testing and next generation sequencing, in addition to the updated international guidelines which downplay the importance of positive family history of LFS [32, 33], have led to dramatic increase in TP53 testing, especially among young BC patients. The gene discussed is TP53; the disease is breast cancer.